Mary Reumuth

Mary Reumuth is the Chief Financial Officer at Kala Pharmaceuticals. Mary has over 10 years of experience in the pharmaceutical industry, including their previous role as Vice President, Finance and Corporate Controller at Kala Pharmaceuticals from February 2014 to February 2017. Prior to that, they were the Corporate Controller at Enobia Pharma Corp from May 2011 to June 2012, where they were responsible for building the accounting and finance organization, relocating accounting operations to Cambridge, MA from Montreal, and leading the treasury function. Mary also has experience as a Director, Corporate Financial Planning & Analysis at Verenium Corporation from December 2007 to March 2011.

Mary Reumuth obtained their Bachelor of Business Administration (B.B.A.) in Accounting from Texas A&M University-Corpus Christi. Mary is also a Certified Public Accountant (CPA).

Mary Reumuth reports to Mark Iwicki, Chairman & CEO. They are on a team with Susan Coultas - SVP, Clinical Development, Vincent Kosewski - Senior Vice President of Manufacturing and Supply Chain Management, and Kate Kline - SVP, Marketing.